Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells

Our findings demonstrate that Siglec-8 can be exploited as an endocytic receptor to deliver drugs or toxins to kill human eosinophils and mast cells. This approach holds promise to treat diseases involving these cell types.

http://ift.tt/2tIsGQW